Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical
Olympus Corporation, a global MedTech company committed to making people’s lives healthier, safer and more […]
Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest
Accenture has acquired Bionest, a strategy and consulting firm dedicated to addressing complex strategic decisions […]
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point of need, […]
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Crown Bioscience to Acquire Indivumed Service Business and Supporting Biobank
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has […]
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata
Sun Pharma and Concert Pharmaceuticals today announced that they have executed a definitive agreement under […]
Machine Solutions Acquires Vela Technologies
Machine Solutions, a provider of advanced equipment and services for the medical device market, has […]
Pheno Therapeutics Announces Worldwide License from UCB to a Novel Program for Neurodegenerative Disease
Pheno Therapeutics, a biotechnology company focused on the discovery and development of small molecule therapeutics […]
JanOne Completes Acquisition of Soin Therapeutics
JanOne, a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced […]
Vistagen to Acquire Pherin Pharmaceuticals
Vistagen, a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more